Spasticity patients: Special considerations

Seminars in Pain Medicine

Volumn 2, Issue 1, 2004, Pages 36-42

  Bethoux, Francois ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Central nervous system; Intrathecal injection; Spasticity

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLONIDINE; CYPROHEPTADINE; DANTROLENE; GABAPENTIN; LOCAL ANESTHETIC AGENT; OPIATE; PHENOL; SPASMOLYTIC AGENT; TIZANIDINE;

ARM MOVEMENT; ARTICLE; BRAIN INJURY; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL PALSY; CEREBROSPINAL FLUID FISTULA; CLINICAL EXAMINATION; COMA; CONFUSION; CORDOTOMY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG OVERDOSE; EVIDENCE BASED MEDICINE; FATIGUE; FEVER; GAIT; HALLUCINATION; HEALTH STATUS; HUMAN; HYPOTENSION; LIVER DYSFUNCTION; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MEDICATION ERROR; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; MUSCLE RESECTION; MUSCLE STIFFNESS; MUSCLE WEAKNESS; NEURECTOMY; OCCUPATIONAL THERAPY; ORTHOSIS; PARESTHESIA; PATIENT EDUCATION; PATIENT SELECTION; PHYSICAL CAPACITY; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATION DEPRESSION; RHIZOTOMY; RISK ASSESSMENT; SEDATION; SEIZURE; SEROMA; SOMNOLENCE; SPASTICITY; SPINAL CORD INJURY; STANDARDIZATION; SURGICAL TECHNIQUE; SYMPTOM; TENDON SURGERY; TENDON TRANSFER; TREATMENT PLANNING; VISUAL ANALOG SCALE; VOCATIONAL REHABILITATION; WALKING; WOUND DEHISCENCE;

EID: 3543146025     PISSN: 15375897     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spmd.2003.10.005     Document Type: Article

References (39)

1. Lance J. Symposium synopsis Feldman R.G. Young R.R. Koella W.P. (Eds.). Spasticity: Disordered Motor Control 1980 485-494 Year Book Medical Chicago, IL
2. Young R. Spasticity : A review Neurology 44 suppl 1994 S12-S20
3. Ashworth B. Preliminary trial of carisodoprol in multiple sclerosis Practitioner 192 1964 540-542
4. Bohannon R. Smith M. Inter-rater reliability of a modified Ashworth scale of muscle spasticity Phys Ther 67 1987 206-207
5. Penn R.D. Savoy S.M. Corocs D. et al. Intrathecal baclofen for severe spinal spasticity N Engl J Med 320 1989 1517-1521
6. Bajd T. Vodovnik L. Pendulum testing of spasticity J Biomed Eng 6 1984 9-16
7. Delwaide P. Human monosynaptic reflexes and presynaptic inhibition: An interpretation of spastic hyperreflexia Desmedt J. (Ed.). New Developments in Electromyography and Clinical Neurophysiology 1973 Karger Basel
8. The WE MOVE Spasticity Study Group: Dosing, administration, and a treatment algorithm for use of botulinum toxin type A for adult-onset muscle overactivity in patients with an upper motoneuron lesion Mayer N.H. Simpson D.M. (Eds.). Spasticity. Etiology, Evaluation, Management and the Role of Botulinum Toxin 2002 154-165 WE MOVE New York
9. Sindou M. Millet M. Mortamais J. et al. Results of selective posterior rhizotomy in the treatment of painful and spastic paraplegia secondary to multiple sclerosis Appl Neurophysiol 45 1982 335-340
10. Delehanty L. Sadiq S. Use of combination intrathecal baclofen and morphine in MS patients with intractable pain and spasticity Neurology 56 2001 A99
11. Masterson M. Sadiq S. Use of intrathecal clonidine infusion alone, or in combination with intrathecal baclofen, for relief of intractable pain syndromes Neurology 56 2001 A351
12. Azouvi P. Mane M. Thiebaut J. et al. Intrathecal baclofen administration for control of severe spinal spasticity : Functional improvement and long-term follow-up Arch Phys Med Rehabil 77 1996 35-39
13. Denys P. Chartier-Kastler E. Azouvi P. et al. Intrathecal clonidine for refractory detrusor hyperreflexia in spinal cord injured patients: A preliminary report J Urol 160 1998 2137-2138
14. Zierski J. Muller H. Dralle D. et al. Implanted pump systems for treatment of spasticity Acta Neurochirurgica 43 suppl 1988 94-99
15. Penn R.D. Savoy S.M. Corcos D. et al. Intrathecal baclofen for severe spinal spasticity N Engl J Med 320 1989 1517-1521
16. Coffe Y. JR. Cahill D. Steers W. et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study J Neurosurg 78 1993 226-232
17. Abel N.A. Smith R.A. Intrathecal baclofen for treatment of intractable spinal spasticity Phys Med Rehabil 75 1994 54-58
18. Nance P. Schryvers O. Schmidt B. et al. Intrathecal baclofen therapy for adults with spinal spasticity: Therapeutic efficacy and effect on hospital admissions Can J Neurol Sci 22 1995 22-29
19. Korenkov A.I. Niendorf W.R. Darwish N. et al. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries Neurosurg Rev 25 2002 228-230
20. Gianino J.M. York M.M. Paice J.A. et al. Quality of life : Effect of reduced spasticity from intrathecal baclofen J Neurosci Nurs 30 1998 47-54
21. Stempien L. Tsai T. Intrathecal baclofen pump use for spasticity Am J Phys Med Rehabil 79 2000 536-541
22. Jarrett L. Siobhan M. Porter B. et al. Managing spasticity in people with multiple sclerosis: A goal-oriented approach to intrathecal baclofen therapy Int J MS Care 3 2001 10-21
23. Sylvester A. Sadiq S. Long term use of intrathecal baclofen infusion in ambulatory patients with spasticity Neurology 56 2001 A26
24. Bethoux F. Gogol D. Schwetz K. et al. Use of a registry of intrathecal baclofen therapy in a large multiple sclerosis center : Analysis of data on 82 patients and proposed changes Arch Phys Med Rehabil 82 2001 1329
25. Auer C. Siebner H. Dressnandt J. et al. Intrathecal baclofen increases corticospinal output to hand muscles in multiple sclerosis Neurology 52 1999 1298-1299
26. Meythaler J.M. Guin-Renfroe S. Grabb P. et al. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience Arch Phys Med Rehabil 80 1999 13-19
27. Becker R. Alberti O. Bauer B.L. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury J Neurol 244 1997 160-166
28. Francois B. Vacher P. Roustan J. Intrathecal baclofen after traumatic brain injury: Early treatment using a new technique to prevent spasticity J Trauma-Injury Infect Crit Care 50 2001 158-161
29. Cuny E. Richer E. Castel J.P. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal baclofen therapy Brain Injury 15 2001 917-925
30. Gerszten P.C. Albright A.L. Barry M.J. Effect on ambulation of continuous intrathecal baclofen infusion Pediatr Neurosurg 27 1997 40-44
31. Meythaler J.M. Guin-Renfroe S. Brunner R.C. et al. Intrathecal baclofen for spastic hypertonia from stroke Stroke 32 2001 2099-2109
32. Murphy N.A. Irwin M.C. Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications Arch Phys Med Rehabil 83 2002 1721-1725
33. Gilmartin R. Bruce D. Storrs B.B. et al. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial J Child Neurol 15 2000 71-77
34. Armstrong R.W. Steinbok P. Cochrane D.D. et al. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin J Neurosurg 87 1997 409-414
35. Albright A.L. Barron W.B. Fasick M.P. et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin JAMA 270 1993 2475-2477
36. Meythaler J.M. Guin-Renfroe S. Law C. et al. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy Arch Phys Med Rehabil 82 2001 155-1561
37. Albright A.L. Barry M.J. Shafton D.H. et al. Intrathecal baclofen for generalized dystonia Devel Med Child Neurol 43 2001 652-657
38. Postma T.J. Oenema D. Terpstra S. et al. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system Pharmacoeconomics 15 1999 395-404
39. Nielsen J.F. Hansen H.J. Sunde N. et al. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen Clin Neurol Neurosurg 104 2002 142-145